Sat, Feb 28, 2015, 6:45 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Tonix Pharmaceuticals Holding Corp Message Board

  • thebigfella1234 thebigfella1234 Aug 9, 2013 9:38 AM Flag

    whoomp there it is

    well, we knew it was coming and here it is. at least they took some of the sting away with the uplist news. gonna let the smoke clear and possibly take a position. im a little spread out at the moment, so il have to wait and see. market timing can be a cruel mistress

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • From Jason Napodano:

      "$TNXP raises $11.5M, uplists to NASDAQ. Plans p2b fibromyalgia study with TNX-102SL this fall. Map = ~$20M. Very low-float."

      Pardon my stupidity, but what is Map (as in Map = ~20M)?

    • You nailed it bigfella...with regard to market timing, the good thing about a bio-tech is the fact that it really should be "market" neutral. They are event driven. I had a few bio tech stocks that did very well when the market got clobbered in 2008. They continued to perform well for the next several years despite a volatile market. I will be curious to see how much support Roth Capital gives this stock. A few good research reports, conferences and events could push this stock a lot higher. The current valuation is tiny for a company with this much potential. Look at MAPP pharma. I believe they got taken out for close to a 1 Bil market cap. Their drug was also a re-formulation of an existing drug. I also believe this was prior to final phase III results. If TNXP got taken out at a 100MM valuation, I would be a very happy camper. With regard to my "handle", I love dogs as well. I worked for a guy who was a vet who had the nick-name Dogbeater while he was in Korea. He is no longer alive, but he was a great man.

 
TNXP
5.95-0.05(-0.83%)Feb 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.